Company Recordati

REC

IT0003828271

Pharmaceuticals

Market Closed - Borsa Italiana Other stock markets 11:45:00 2025-01-24 am EST			5-day change	1st Jan Change
56.00 ^EUR	+0.36%		+2.00%	+10.67%

Jan. 17	Recordati and its top investor say no plans for deal with Angelini	RE
Jan. 17	Recordati-Angelini, on the plan interest of sovereign wealth funds	AN

Business description: Recordati

Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:

- pharmaceutical and OTC products (65.7%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;

- medicines for rare diseases (34.3%).

Net sales are distributed geographically as follows: Italy (15.2%), Europe (56.4%), America (19%), Asia and Oceania (6.7%) and Africa (2.7%).

Number of employees: 4,455

Sales by Activity: Recordati

Fiscal Period: December	2019	2020	2021	2022	2023
Specialty & Primary Care	1.23B	1.13B	1.2B	1.26B	1.37B
Rare Diseases	250M	319M	384M	596M	715M

See all business segments

Geographical breakdown of sales: Recordati

Fiscal Period: December	2019	2020	2021	2022	2023
United States of America	117M	128M	182M	268M	323M
Italy	283M	271M	263M	275M	313M
Other International	202M	201M	204M	229M	266M
France	157M	144M	152M	169M	180M
Spain	94.7M	83.82M	120M	143M	165M
Other Western European	77.58M	91.12M	104M	137M	152M
Germany	139M	136M	153M	168M	151M
Other Eastern European	82.11M	91.98M	112M	129M	150M
Russia, Ukraine, Other CIS	120M	100M	99.6M	132M	141M
Turkey	88.61M	79.19M	70.31M	74.34M	97.52M
Portugal	44.45M	42.72M	45.43M	53.46M	60.2M
North Africa	40.32M	41.25M	35.9M	37.66M	40.22M
Australasia	15.01M	16.88M	14.52M	16.99M	21.53M
Europe Excluding Italy	14.64M	15.24M	17.14M	14.35M	15.21M
America (U.S.A. Excluded)	4.38M	4.58M	4.76M	4.72M	5.54M
Africa	1.19M	1.5M	1.68M	2.58M	1.33M

See all geographic segments

Managers: Recordati

Director	Title	Age	Since
Robert Koremans CEO	Chief Executive Officer	62	2021-11-30
Luigi la Corte DFI	Director of Finance/CFO	55	2019-10-31
Raffaele Sabia CTO	Chief Tech/Sci/R&D Officer	-	2017-06-30
Federica de Medici IRC	Investor Relations Contact	52	2020-09-30
Maria Lamelas Godinez HRO	Human Resources Officer	-	2022-12-31

See RECORDATI governance

Members of the board: Recordati

Manager	Title	Age	Since
Andrea Recordati CHM	Chairman	53	2021-11-30
Michaela Castelli BRD	Director/Board Member	54	2014-04-16
Giampiero Mazza CHM	Chairman	55	2018-06-11
Cathrin Petty BRD	Director/Board Member	51	2018-06-11
Joanna Le Couilliard BRD	Director/Board Member	61	2019-02-04
Luigi la Corte BRD	Director/Board Member	55	2020-04-28
Piergiorgio Peluso BRD	Director/Board Member	56	2020-04-28
Guido Guidi BRD	Director/Board Member	71	2020-04-28
Giorgio De Palma BRD	Director/Board Member	50	2020-04-28
Robert Koremans BRD	Director/Board Member	62	-

Composition of the Board of Directors

Shareholders: Recordati

Name	Equities	%	Valuation
CVC Advisers Ltd. 51.82 %	108,368,721	51.82 %	5 692 M €
Fidelity Management & Research Co. LLC 3.527 %	7,375,844	3.527 %	387 M €
Invesco Asset Management Ltd. 2.278 %	4,763,871	2.278 %	250 M €
Fundsmith LLP 1.435 %	3,000,492	1.435 %	158 M €
RECORDATI 1.319 %	2,758,646	1.319 %	145 M €

List of RECORDATI shareholders

Holdings: Recordati

Name	Equities	%	Valuation
RECORDATI 1.32%	2,758,646	1.32%	144,898,792 $
PURETECH HEALTH PLC 3.95%	9,457,319	3.95%	17,790,163 $

Company details: Recordati

Recordati SpA

Via Matteo Civitali, 1

20148, Milan

+39 02 487871

http://www.recordati.it/

Group companies: Recordati

Name	Category and Sector
Herbacos Recordati sro Herbacos Recordati sro Household/Personal CareConsumer Non-Durables Part of CVC Advisers Ltd., Herbacos Recordati sro is a Czech company that manufactures and distributes cosmetic products. The company is located in Czechia.	Household/Personal Care
Recordati AG Recordati AG Drugstore ChainsRetail Trade Recordati AG engages in the trading in as well as importation and exportation of pharmaceutical, biological, chemical, laboratory, and diagnostic products. It also provides consulting services in the areas of marketing and management, with focus on the pharmaceutical industry. The company was founded on June 8, 2011 and is headquartered in Baar, Switzerland.	Drugstore Chains
Recordati Ireland Ltd. Recordati Ireland Ltd. Pharmaceuticals: MajorHealth Technology Recordati Ireland Ltd. manufactures pharmaceutical products. It offers pharmaceuticals in the therapeutic areas of cardiovascular, antibiotics and antivirals, central nervous system, gastroenterology, dermatological, muscolo-skeletal disorders, genito-urinary system and pain therapy, obstetics and gynaecology and OTC (non-prescription pharmaceuticals). The company was founded in 2002 and is headquartered in Cork, Ireland.	Pharmaceuticals: Major
Recordati Ilac San ve Tic AS	Pharmaceuticals: Major
Recordati BVBA Recordati BVBA Medical DistributorsDistribution Services Part of CVC Advisers Ltd., Recordati BV is a trading brokerage in pharmaceutical products and orthopedic articles. The company is located in Belgium.	Medical Distributors

See all subsidiaries

Other Pharmaceuticals

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
RECORDATI	+0.36%	+2.00%	+12.13%	+10.85%	12.04B
ELI LILLY AND COMPANY	+2.45%	+8.22%	+23.94%	+226.68%	707B
NOVO NORDISK A/S	+7.13%	+8.13%	-14.15%	+104.43%	389B
JOHNSON & JOHNSON	+0.12%	-0.14%	-7.64%	-9.91%	353B
ABBVIE INC.	-0.22%	-0.73%	+3.70%	+28.86%	301B
ROCHE HOLDING AG	+0.18%	+3.58%	+12.14%	-20.26%	244B
MERCK & CO., INC.	-1.12%	-2.42%	-19.62%	+21.21%	242B
ASTRAZENECA PLC	+0.04%	+1.02%	+5.70%	+32.88%	214B
NOVARTIS AG	0.00%	+1.05%	-3.50%	+17.60%	199B
AMGEN INC.	-0.89%	+1.22%	-9.85%	+21.82%	148B
Average	+0.80%	+2.32%	+0.29%	+43.42%	281.05B
Weighted average by Cap.	+1.47%	+3.45%	+2.59%	+78.37%